The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data

The severe acute respiratory syndrome coronavirus 2 pandemic has dominated the global health scenario from the beginning of 2020 and still represents a major health emergency. Cytokine inhibitors as tocilizumab have been used to treat COVID-19 severe pneumonia with conflicting results. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Capici, Serena, Sala, Luca, Galimberti, Stefania, Valsecchi, Maria Grazia, Squillace, Nicola, Gustinetti, Giulia, Cazzaniga, Marina Elena, Bonfanti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053531/
https://www.ncbi.nlm.nih.gov/pubmed/33880043
http://dx.doi.org/10.2147/IDR.S304414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053531/
https://www.ncbi.nlm.nih.gov/pubmed/33880043
http://dx.doi.org/10.2147/IDR.S304414

Ejemplares similares